More options available for corneal repair

Article

Corneal transplantation is moving away from penetrating keratoplasty toward less invasive endothelial keratoplasty procedures in which only the damaged portion of the cornea is removed and replaced with donor cells.

Key Points

Chehalis, WA-Corneal transplantation is moving away from penetrating keratoplasty (PK) toward less invasive endothelial keratoplasty (EK) procedures in which only the damaged portion of the cornea is removed and replaced with donor cells, according to David Stanfield, OD, FAAO.

While PK is a well-established procedure that generally produces excellent visual results, it has several drawbacks that have spurred surgeons to develop and modify EK techniques, said Dr. Stanfield, Pacific Cataract and Laser Institute, Chehalis, WA.

Following PK, the possibility that the wound will reopen is a concern for at least a year and potentially for the patient's lifetime. Other issues include corneal irregularities and the risk of infection from sutures. A major drawback with conventional PK is that those patients usually develop significant amounts of induced corneal astigmatism, prolonging visual recovery.

EK options

EK was first performed in the 1950s, but was not pursued aggressively until the late 1990s. Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's stripping endothelial keratoplasty (DSEK) are the most commonly performed EK procedures today, Dr. Stanfield said.

"Early EK procedures-including posterior lamellar keratoplasty (PLK) and deep lamellar endothelial keratoplasty (DLEK)-have been refined as surgeons gained experience. The current menu of procedures includes DSAEK, DSEK, and Descemet's membrane endothelial keratoplasty (DMEK). DSEK and DSAEK have a good track record," he said.

Postoperative visual recovery is usually excellent, and with DMEK, a greater percentage of patients have 20/20 visual acuity compared with traditional PK, DSEK, and DSAEK. Visual rehabilitation typically occurs within a few weeks, compared to a year or more with penetrating keratoplasty.

In DSAEK, donor tissue is transferred to an artificial chamber, an automated microkeratome is activated, and donor tissue is trephined. During DSEK procedures, the donor is manually prepared. Steps for preparing the recipient cornea are stripping and removing the Descemet's membrane, folded insertion of the donor through a small, temporal incision, unfolding the tissue with an air bubble, and removal of some of the air.

In patients undergoing DSAEK or DSEK, the donor endothelium is attached to a small layer of stroma. Although the cornea can be remarkably clear postoperatively in these patients, vision may be less than anticipated, probably due to the fact that the extra stromal layer creates a more irregular optical interface.

Recent Videos
Bonnie An Henderson in an interview for the EnVision Summit
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
© 2024 MJH Life Sciences

All rights reserved.